Improving glucose management:: Ten steps to get more patients with type 2 diabetes to glycaemic goal -: Recommendations from the Global Partnership for Effective Diabetes Management

被引:110
作者
Del Prato, S
Felton, AM
Munro, N
Nesto, R
Zimmet, P
Zinman, B
机构
[1] Univ Pisa, Dept Endocrinol & Metab, Sect Diabet, Osped Cisanello, I-56124 Pisa, Italy
[2] Federat European Nurses Diabet, London, England
[3] Primary Care Diabet Europe, Surrey, England
[4] Lahey Clin Fdn, Burlington, MA USA
[5] Int Diabet Inst, Caulfield, Australia
[6] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
关键词
glycaemic control; glycaemic targets; patient management; type; 2; diabetes;
D O I
10.1111/j.1742-1241.2005.00674.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite increasingly stringent clinical practice guidelines for glycaemic control, the implementation of recommendations has been disappointing, with over 60% of patients not reaching recommended glycaemic goals. As a result, current management of glycaemia falls significantly short of accepted treatment goals. The Global Partnership for Effective Diabetes Management has identified a number of major barriers that can prevent individuals from achieving their glycaemic targets. This article proposes 10 key practical recommendations to aid healthcare providers in overcoming these barriers and to enable a greater proportion of patients to achieve glycaemic goals. These include advice on targeting the underlying pathophysiology of type 2 diabetes, treating early and effectively with combination therapies, adopting a holistic, multidisciplinary approach and improving patient understanding of type 2 diabetes. Implementation of these recommendations should reduce the risk of diabetes-related complications, improve patient quality of life and impact more effectively on the increasing healthcare cost related to diabetes.
引用
收藏
页码:1345 / 1355
页数:11
相关论文
共 95 条
[1]  
*ALAD, 2000, REV ASOC LATINOAM S1, V8, P101
[2]  
*AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P40
[3]  
*AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS15
[4]  
[Anonymous], 1999, Diabet Med, V16, P716
[5]  
[Anonymous], 1995, Diabetes, V44, P1249
[6]  
[Anonymous], 1995, DIABETES, V44, P968
[7]  
*AS PAC TYP 2 DIAB, 2002, TYP 2 DIAB PRACT TAR
[8]   Earlier intervention in type 2 diabetes: The case for achieving early and sustained glycaemic control [J].
Bailey, CJ ;
Del Prato, S ;
Eddy, D ;
Zinman, B .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (11) :1309-1316
[9]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[10]   Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea [J].
Baksi, A ;
James, RE ;
Zhou, B ;
Nolan, JJ .
ACTA DIABETOLOGICA, 2004, 41 (02) :63-69